Comments
Commented by Armin Schulz on November 20th, 2024 | 07:00 CET
Evotec, Nyxoah, Bayer – A lot of excitement in the healthcare industry
The healthcare sector is currently abuzz with activity. Evotec is the focus of a potential takeover by the US company Halozyme, which has caused the shares of the German biotech company to skyrocket. At the same time, the Belgian medical technology company Nyxoah expects to receive FDA approval soon for its Genio system for the treatment of sleep apnea, which would pave the way for its market entry in the US. Bayer, on the other hand, disappointed with its latest quarterly figures, which showed a significant decline in revenue and EBITDA, leading to a slide in its share price. We take a closer look at these three companies.
Read
Commented by Fabian Lorenz on November 19th, 2024 | 07:15 CET
BUYING OPPORTUNITY in gold and billion-dollar investment: Barrick Gold, Thunder Gold, BYD
The price of gold is consolidating, the major gold producers are weakening and they could soon be forced into takeovers. This presents investors with an interesting buying opportunity with promising gold explorers. One of these takeover candidates is Thunder Gold. The Company has a highly promising project in Canada with excellent infrastructure and outstanding resources, which could soon increase further. Then a big player like Barrick Gold could strike. The second-largest gold producer has missed analyst estimates and could keep investors interested through acquisitions. The mood of German automakers is unlikely to improve when they look at BYD. The Chinese are currently celebrating a milestone and announcing a billion-dollar investment program for the integration of artificial intelligence. Should one take advantage of the buying opportunity now?
Read
Commented by André Will-Laudien on November 19th, 2024 | 07:10 CET
Energy-guzzling artificial intelligence – Uranium in focus! Higher prices possible for Palantir, F3 Uranium, SAP and SMCI!
The energy demand is skyrocketing! Currently, high-tech companies from Silicon Valley are investing in power generators and uranium companies. This is because they will all need many times more electricity in the coming years than they do today in order to roll out their AI-driven business models. Artificial intelligence consumes, on average, 10 to 15 times more energy than conventional search engine queries. As a result, industry leaders are no longer willing to leave future energy supplies solely in the hands of governments, as the risk of supply disruptions appears too great. For several months, nuclear companies in the US have been developing so-called small modular reactors, while the EU wants to continue with renewable energies. Investors should weigh these options carefully, as these trends present significant opportunities for growth.
Read
Commented by Armin Schulz on November 19th, 2024 | 07:05 CET
Nel ASA, dynaCERT, Daimler Truck – Decarbonization in focus
Nel ASA, dynaCERT and Daimler Truck are three companies involved in various areas of hydrogen technology, thus contributing to decarbonization. Nel ASA is a pioneer in the production of electrolysers that generate hydrogen from renewable energies. dynaCERT develops innovative systems that integrate hydrogen into combustion engines to reduce emissions. Daimler Truck is committed to hydrogen fuel cells for long-distance transportation and has achieved impressive ranges with the GenH2 Truck. Together, they are driving the use of hydrogen as a clean energy carrier and shaping the future of mobility and energy supply.
Read
Commented by Stefan Feulner on November 19th, 2024 | 07:00 CET
Novo Nordisk, BioNxt Solutions, Bavarian Nordic – Opportunities after a horror week
The past trading week was one to forget for the biotech and medtech sectors. With the nomination of the anti-vaccine Robert F. Kennedy as the future US Secretary of Health, stocks such as Moderna, Pfizer and BioNTech lost disproportionately. Even the broadly diversified Nasdaq Biotech Index closed with a weekly loss of over 10%. However, many analysts see the sudden slide as an attractive entry opportunity.
Read
Commented by André Will-Laudien on November 18th, 2024 | 07:10 CET
Uncertainty, volatility and BTC at USD 100,000? The stock checklist with BYD, VW, 123fahrschule and Mercedes
Donald Trump is moving back into the White House. Investors took the election result as an opportunity to stage a celebration on the US stock market. The major indices recorded a full 10% increase, and the US dollar strengthened significantly. Trump stands for fossil fuels, nuclear power and armaments. He dismisses climate change and the Paris Agreement and will not invest any further funds in the energy transition. This is a warning sign for the European economy because local governments are pursuing a "net zero" target for 2045, and their efforts are globally losing ground. High costs are squeezing the margins of local corporations, whereas US companies and Asian firms are doing brilliantly. For investors, there are many opportunities and timing is more important than ever. We have done the math.
Read
Commented by Stefan Feulner on November 18th, 2024 | 07:05 CET
Bloom Energy, Altech Advanced Materials, FuelCell Energy – Extreme jumps
After the stock market celebrated the quick end of the US elections, a sense of realism returned to the market. The technology exchange Nasdaq, in particular, was hit hard on the last trading day of the week, falling by almost 2.5%. In general, volatility increased significantly in the past trading week. The reason for this lies in the rising yields on US government bonds. A previously priced-in interest rate cut is now once again uncertain.
Read
Commented by Fabian Lorenz on November 18th, 2024 | 07:00 CET
Takeover speculation and momentum: BioNTech, Rheinmetall, Vidac Pharma
BioNTech aims to strengthen its cancer-fighting pipeline by acquiring the Chinese biotech firm Biotheus. The Mainz-based company is laying out up to USD 950 million for the company, which specializes in the development of therapies for cancer and autoimmune diseases. This is the latest example of takeovers in the cancer sector. Vidac Pharma, with a market capitalization of just over EUR 30 million, appears to be favorably valued. Analysts share this view, as Vidac is working on a revolutionary cancer therapy. While Vidac's share price jumped in the second half of the year, Rheinmetall consolidated. Will the defense stock be able to break out with the tailwind from Trump?
Read
Commented by Juliane Zielonka on November 15th, 2024 | 07:00 CET
First Hydrogen, BYD, Porsche - Two newcomers challenge the old guard
Germany is establishing itself as a pioneer in hydrogen mobility with an ambitious 9,700 km hydrogen network and 17 specialized hydrogen centers. The Company First Hydrogen is taking advantage of this momentum and is positioning itself in the German market with its field-tested commercial vehicles at exactly the right time. With an impressive range of 630 km per tank fill and successful fleet trials in the UK, First Hydrogen is making strides. At the same time, Hungary is developing into a strategic hub of European e-mobility. With BYD and BMW setting up operations and the battery manufacturer CATL investing EUR 7.3 billion, a major center for electromobility is emerging here. Once the undisputed star in the automotive sky, Porsche is experiencing a decline in revenue of 5.2% to EUR 28.56 billion and is struggling with a falling operating return. The important Chinese market, particularly, is causing concern for the Stuttgart-based company, where sales figures fell by a third in the first half of the year.
Read
Commented by Juliane Zielonka on November 14th, 2024 | 07:45 CET
Daimler Truck, dynaCERT, Bayer AG: Contrasts in Q3: Established companies under pressure, newcomers with breakthroughs
Established DAX corporations such as Bayer AG and Daimler Truck, a Mercedes-Benz Group company, are facing a headwind in the third quarter of 2024. However, the Canadian cleantech specialist dynaCERT is on the verge of its commercial breakthrough. The Leverkusen-based Bayer Group has to revise its forecast downwards. The agriculture business, in particular, is a cause for concern, while the pharmaceuticals division is scoring points with new drugs. At Daimler Truck, strong business in North America is stabilizing the balance sheet, while business in Europe is under pressure. dynaCERT, on the other hand, has received the valuable Verra certification for its hydrogen technology for diesel optimization after twenty years of development work. Investors finally have a viable hydrogen use case for logistics.
Read